Results 151 to 160 of about 39,749,831 (352)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Barriers and Levers for the Implementation of OCAP™

open access: yesInternational Indigenous Policy Journal, 2014
This article discusses the obstacles to and supports for the implementation of the First Nations Principles of OCAP™, specifically in the context of data holdings within Aboriginal Affairs and Northern Development Canada (AANDC) and the Government of ...
First Nations Information Governance Centre
doaj  

AIE-YOLO: Auxiliary Information Enhanced YOLO for Small Object Detection [PDF]

open access: gold, 2022
Bingnan Yan   +4 more
openalex   +1 more source

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

open access: yesClinical Chemistry, 2009
S. Bustin   +11 more
semanticscholar   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Pre-Training of Deep Bidirectional Protein Sequence Representations With Structural Information [PDF]

open access: gold, 2021
Seonwoo Min   +5 more
openalex   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Los derechos humanos en Gran Bretaña

open access: yesDerecho PUCP, 1965
No contiene ...
Central Office of Information Londres
doaj  

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

open access: yesMolecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra   +10 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2019

open access: yesInformation, 2020
Information Editorial Office
doaj   +1 more source

Home - About - Disclaimer - Privacy